B
BMY
Bristol-Myers Squibb Co.
$59.28
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Bristol-Myers Squibb Co. in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
$2.72
Yield
4.58%
EPS
$4.54
P/E
13.5
Data as of Oct 1
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: $1.74
Oct 29
Posts
No posts about BMY yet.
About Bristol-Myers Squibb Co.
Bristol-Myers Squibb is a large pharmaceutical company that discovers, makes, and sells prescription drugs for cancer, heart disease, and immune disorders. It earns money by selling branded medicines like the blood thinner Eliquis and cancer drug Opdivo to hospitals and pharmacies worldwide, and it also pays out one of the bigger dividends in the drug industry to shareholders.